Abstract
The cardiac troponins have expanded the spectrum of detectable myocardial injury and enhanced the clinician's ability to identify patients with acute coronary syndromes who are at higher risk for death or recurrent ischemic events. Based on available data, it appears most likely that any reliably detected troponin elevation results from myocyte necrosis. This notion has served as the basis for the recent revision of diagnostic criteria for acute myocardial infarction based on cardiac troponin. Nevertheless, further research is necessary to conclusively refute the possibility that the release of cardiac troponins may also occur in the setting of reversible myocyte injury resulting from cellular ischemia. Such an investigation establishing biologic correlates of troponin elevation is likely to prove valuable in guiding diagnostic terminology as well as in therapy. For example, clinical research finding cardiac troponin elevation to be predictive of intracoronary throumbus and distal microvascular obstruction has been important to the evaluation of troponis for targeting powerful antiplatelet and antithrombin therapies. Whether related to irreversible or reversible injury, the cardiac troponins have blurred the traditional boundaries between unstable angina and myocardial infarction and have evolved as powerful tools for risk stratification and therapeutic decision-making.
Similar content being viewed by others
References
Braunwald, E., Antman, E.M., Beasley, J.W., Califf, R.M., Cheitlin, M.D., Hochman, J.S., et al. (2000). ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 102:1193–1209.
Hamm, C.W. and Braunwald E. (2000). A classification of unstable angina revisited. Circulation 102:118–122.
Wu, A.H. and Ford, L. (1999). Release of cardiac troponin in acute coronary syndromes: ischemia or necrosis? Clin. Chim. Acta 284:161–174.
Ahmed, S.A., Williamson, J.R., Roberts, R., Clark, R.E., and Sobel, B.E. (1976). The association of increased plasma MB CPK activity and irreversible ischemic myocardial injury in the dog. Circulation 54:187–193.
Ishikawa, Y., Saffitz, J.E., Mealman, T.L., Grace, A.M., and Roberts, R. (1997). Reversible myocardial ischemic injury is not associated with increased creatine kinase activity in plasma. Clin. Chem. 43:467–475.
Chocron, S., Alwan, K., Toubin, G., Kantelip, B., Clement, F., Kantelip, J.P., et al. (1996). Effects of myocardial ischemia on the release of cardiac troponin I in isolated rat hearts. J. Thorac. Cardiovasc. Surg. 112:508–513.
Chen, Y., Serfass, R.C., Mackey-Bojack, S.M., Kelly, K.L., Titus, J.L., and Apple, F.S. (2000). Cardiac troponin T alterations in myocardium and serum of rats after stressful, prolonged intense exercise. J. Appl. Physiol. 88:1749–1755.
Antman, E.M., Grudzien, C., Mitchell, R.N., and Sacks, D.B. (1997). Detection of unsuspected myocardial necrosis by rapid bedside assay for cardiac troponin T. Am. Heart J. 133:596–598.
Thayapran, N., Prigent, F., Steingart, R., Feng, Y.J., Lowenkron, D., and Wu, A.H. (1997). Is there a release of cardiac troponin during exercise testing? (abstract). Circulation 96:I-461.
La Vecchia, L., Bedogni, F., Finocchi, G., Mezzena, G., Martini, M., Sartori, M., et al. (1997). Troponin T, troponin I and CK-MB (mass) in the detection of periprocedural myocardial damage after coronary angioplasty. Cardiologia 42:405–413.
Topol, E.J. and Yadav, J.S. (2000). Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 101:570–580.
Hamm, C.W., Heeschen, C., Goldmann, B., Vahanian, A., Adgey, J., Miguel, C.M., et al. (1999). Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. N. Engl. J. Med. 340:1623–1629.
Heeschen, C., van Den Brand, M.J., Hamm, C.W., and Simmons, M.L. (1999). Angiographic findings in patients with refractory unstable angina according to troponin T status. Circulation 100:1509–1514.
Matetzky, S., Sharir, T., Domingo, M., Noc, M., Chyu, K.Y., Kaul, S., et al. (2000). Elevated troponin I level on admission is associated with adverse outcome of primary angioplasty in acute myocardial infarction. Circulation 102:1611–1616.
Topol, E.J. (2000). Inflammation and embolization in ischemic heart disease. J. Invasive Cardiol. 12(Suppl. B): 2B-7B.
The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction (2000). Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J. Am. Coll. Cardiol. 36:959–969.
Jaffe, A.S., Ravkilde, J., Roberts, R., Naslund, U., Apple, F.S., Galvani, M., et al. (2000). Its time for a change to a troponin standard. Circulation 102:1216–1220.
Olatidoye, A.G., Wu, A.H., Feng, Y.J., and Waters, D. (1998). Prognostic role of troponin T versus troponin I in unstable angina pectoris for cardiac events with meta-analysis comparing published studies. Am. J. Cardiol. 81: 1405–1410.
Morrow, D.A., Rifai, N., Tanasijevic, M.J., Wybenga, D.R., de Lemos, J.A., and Antman, E.M. (2000). Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: a thrombolysis in myocardial infarction (TIMI) 11B substudy. Clin. Chem. 46:453–460.
Heeschen, C., Hamm, C.W., Goldmann, B., Deu, A., Langenbrink, L., and White, H.D. (1999). Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. Lancet 354:1757–1762.
Lindahl, B., Venge, P., and Wallentin, L. (1997). Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group. J. Am. Coll. Cardiol. 29:43–48.
Morrow, D.A., Antman, E.M., Tanasijevic, M., Rifai, N., de Lemos, J.A., McCabe, C.H., et al. (2000). Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI 11B substudy. J. Am. Coll. Cardiol. 36:1812–1817.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Morrow, D.A. Troponins in patients with acture coronary syndromes. Cardiovasc Toxicol 1, 105–110 (2001). https://doi.org/10.1385/CT:1:2:105
Issue Date:
DOI: https://doi.org/10.1385/CT:1:2:105